CSF oligoclonal bands in neurological diseases besides CNS inflammatory demyelinating disorders

被引:0
作者
Ren, Jingru [1 ]
Wang, Jianchun [2 ]
Liu, Ran [2 ]
Guo, Jing [2 ]
Yao, Yan [2 ]
Hao, Hongjun [2 ]
Gao, Feng [2 ]
机构
[1] Peking Univ First Hosp, Beijing, Peoples R China
[2] Peking Univ First Hosp, Dept Neurol, Beijing, Peoples R China
关键词
CSF DYNAMICS; NEUROIMMUNOLOGY; AUTOIMMUNE ENCEPHALITIS; PERIPHERAL NEUROPATHOLOGY; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; DIAGNOSIS; IMMUNOGLOBULINS;
D O I
10.1136/bmjno-2024-000912
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To understand the distribution characteristics and clinical significance of cerebrospinal fluid (CSF) oligoclonal bands (OCBs) in different nervous system diseases besides typical central nervous system (CNS) inflammatory demyelinating disorders.Material A total of 2259 patients who underwent CSF examination for OCBs at Peking University First Hospital from January 2011 to December 2023 were tested. A cohort of 257 patients presenting with various types of OCBs but without CNS inflammatory demyelinating diseases was included in the analysis. Relevant medical history was collected from all patients.Results OCBs were most common in patients with autoimmune encephalitis. OCB types II and III were most common in patients with autoimmune encephalitis and CNS infection, whereas OCB types IV and V were present in immune-mediated neuropathy mostly. The distribution of OCBs also varied among different disease subtypes. Other CSF characteristics varied between diseases with different OCBs.Conclusions In addition to CNS inflammatory demyelinating diseases, OCBs also appear in other neurological diseases including cerebral angiopathy and neurodegenerative conditions, informing the potential immune background. Further research is still needed to determine the significance of OCBs in these diseases.
引用
收藏
页数:7
相关论文
共 18 条
[1]   PRIMARY SJOGRENS-SYNDROME WITH CENTRAL-NERVOUS-SYSTEM DISEASE MIMICKING MULTIPLE-SCLEROSIS [J].
ALEXANDER, EL ;
MALINOW, K ;
LEJEWSKI, JE ;
JERDAN, MS ;
PROVOST, TT ;
ALEXANDER, GE .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (03) :323-330
[2]   CEREBROSPINAL-FLUID IN THE DIAGNOSIS OF MULTIPLE-SCLEROSIS - A CONSENSUS REPORT [J].
ANDERSSON, M ;
ALVAREZCERMENO, J ;
BERNARDI, G ;
COGATO, I ;
FREDMAN, P ;
FREDERIKSEN, J ;
FREDRIKSON, S ;
GALLO, P ;
GRIMALDI, LM ;
GRONNING, M ;
KEIR, G ;
LAMERS, K ;
LINK, H ;
MAGALHAES, A ;
MASSARO, AR ;
OHMAN, S ;
REIBER, H ;
RONNBACK, L ;
SCHLUEP, M ;
SCHULLER, E ;
SINDIC, CJM ;
THOMPSON, EJ ;
TROJANO, M ;
WURSTER, U .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (08) :897-902
[3]   Oligoclonal bands: clinical utility and interpretation cues [J].
Carta, Sara ;
Ferraro, Diana ;
Ferrari, Sergio ;
Briani, Chiara ;
Mariotto, Sara .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2022, 59 (06) :391-404
[4]   Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis -: A consensus statement [J].
Freedman, MS ;
Thompson, EJ ;
Deisenhammer, F ;
Giovannoni, G ;
Grimsley, G ;
Keir, G ;
Öhman, S ;
Racke, MK ;
Sharief, M ;
Sindic, CJM ;
Sellebjerg, F ;
Tourtellotte, WW .
ARCHIVES OF NEUROLOGY, 2005, 62 (06) :865-870
[5]  
Hong Sang Bin, 2021, Encephalitis, V1, P7, DOI 10.47936/encephalitis.2020.00038
[6]   CSF oligoclonal IgG bands are not associated with ALS progression and prognosis [J].
Klose, Veronika ;
Jesse, Sarah ;
Lewerenz, Jan ;
Kassubek, Jan ;
Dorst, Johannes ;
Tumani, Hayrettin ;
Ludolph, Albert C. ;
Roselli, Francesco .
FRONTIERS IN NEUROLOGY, 2023, 14
[7]  
Koike H, 2000, NEUROPATHOLOGY, V20, pS69
[8]  
LATOV N, 1988, CRIT REV NEUROBIOL, V3, P301
[9]   PRINCIPLES OF ALBUMIN AND IGG ANALYSES IN NEUROLOGICAL DISORDERS .3. EVALUATION OF IGG SYNTHESIS WITHIN CENTRAL NERVOUS-SYSTEM IN MULTIPLE-SCLEROSIS [J].
LINK, H ;
TIBBLING, G .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1977, 37 (05) :397-401
[10]  
Liu X N, 2021, Zhonghua Yi Xue Za Zhi, V101, P2465, DOI 10.3760/cma.j.cn112137-20201127-03210